Navigation Links
Care Investment Trust Inc. Announces an Agreement in Principle for CIT Healthcare to Purchase Mortgage Assets and Reduce Management Fee
Date:8/12/2008

NEW YORK, Aug. 12 /PRNewswire-FirstCall/ -- Care Investment Trust Inc. (NYSE: CRE) ("Care"), a real estate investment and finance company investing in healthcare-related real estate and commercial mortgage debt, today announced an agreement in principle with its external manager, CIT Healthcare that includes the following terms:

-- Care will receive an option to require CIT Healthcare to purchase up to $125 million of mortgage assets on an individual basis at any time over the next twelve months.

-- The assets will be sold at the fair market value at the time of sale as determined by an independent third party.

-- Care's management fee payable to CIT Healthcare shall be reduced from 1.75% to 0.875% of book equity, decreasing current expenses by approximately $2.5 million per annum.

-- Care will issue 400,000 ten-year warrants at a strike price of $17 per share to CIT Healthcare under its Manager Equity Plan.

F. Scott Kellman, stated, "These important steps ensure that Care will have the liquidity and earnings to accelerate the Company's transformation to a growing healthcare REIT. The Company has an attractive pipeline of investment opportunities which can now be aggressively pursued with the liquidity provided by these new arrangements."

About Care Investment Trust

Care Investment Trust Inc. is a real estate investment and finance company investing in healthcare-related real estate and commercial mortgage debt. It is externally managed and advised by CIT Healthcare LLC, a wholly-owned subsidiary of CIT Group Inc.

Safe Harbor Statement

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements (including statements regarding future financial and operating results) involve risks, uncertainties and contingencies, many of which are beyond Care Investment Trust's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," "target," and similar expressions are generally intended to identify forward-looking statements. Economic, business, funding market, competitive and/or regulatory factors, among others, affecting Care Investment Trust's businesses are examples of factors that could cause actual results to differ materially from those described in the forward-looking statements in addition to those factors specified in Care Investment Trust's Annual Report on Form 10-K for the year ended December 31, 2007. Care Investment Trust is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

For more information on the company, please visit the company's website at http://www.carereit.com


'/>"/>
SOURCE Care Investment Trust Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. £5 million investment in personalized medicines to cut patient deaths
2. Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles
3. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
4. Experts Agree. Ohios Technology Investment Future Looks Bright
5. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Blue Cross of California Invests $10.6 Million in Community Clinics Through the Investment in a Healthy California Program
8. MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC
9. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
10. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
11. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: